The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation

EMBO Molecular Medicine

Volumn 6, Issue 10, 2014, Pages 1328-1346

  Abot, Anne ^a   Fontaine, Coralie ^a   Buscato, Mélissa ^a   Solinhac, Romain ^a   Flouriot, Gilles ^b   Fabre, Aurélie ^a   Drougard, Anne ^a   Rajan, Shyamala ^c   Laine, Muriel ^c   Milon, Alain ^d   Muller, Isabelle ^d   Henrion, Daniel ^e   Adlanmerini, Marine ^a   Valéra, Marie Cécile ^a   Gompel, Anne ^f   Gerard, Céline ^g   Péqueux, Christel ^g   Mestdagt, Mélanie ^g   Raymond Letron, Isabelle ^h   Knauf, Claude ^a   Ferriere, François ^b   Valet, Philippe ^a   Gourdy, Pierre ^a   Katzenellenbogen, Benita S ⁱ   Katzenellenbogen, John A ⁱ   Lenfant, Françoise ^a   Greene, Geoffrey L ^c   Foidart, Jean Michel ^g   Arnal, Jean François ^a   more..

^a Université de Toulouse   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e UNIVERSITÉ D'ANGERS   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g UNIVERSITY OF LIÈGE   (Belgium)

^h UNIVERSITÉ DE TOULOUSE   (France)

ⁱ UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Endothelium; Estetrol; Estrogen receptor; Uterus

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTETROL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROMA; BINDING AFFINITY; CELL PROLIFERATION; CRYSTAL STRUCTURE; ENDOTHELIUM; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HELA CELL LINE; HEPG2 CELL LINE; HISTOLOGY; HUMAN; HUMAN CELL; HYDROGEN BOND; LIGAND BINDING; LIPID STORAGE; MCF 7 CELL LINE; MEMBRANE INITIATED STEROID SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION; UPREGULATION; UTERUS; ANIMAL; C57BL MOUSE; CELL MEMBRANE; CELL NUCLEUS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; GENETICS; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; METABOLISM; OVARIECTOMY; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; ESTETROL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION; HELA CELLS; HEP G2 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MCF-7 CELLS; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, MOLECULAR; MOLECULAR STRUCTURE; OVARIECTOMY; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTERUS;

EID: 84908099857     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.15252/emmm.201404112     Document Type: Article

References (53)

1. Abot A, Fontaine C, Raymond-Letron I, Flouriot G, Adlanmerini M, Buscato M, Otto C, Berges H, Laurell H, Gourdy P et al (2013) The AF-1 activation function of estrogen receptor alpha is necessary and sufficient for uterine epithelial cell proliferation in vivo. Endocrinology 154: 2222-2233
2. Acconcia F, Ascenzi P, Fabozzi G, Visca P, Marino M (2004) S-palmitoylation modulates human estrogen receptor-alpha functions. Biochem Biophys Res Commun 316: 878-883
3. Acconcia F, Marino M (2011) The effects of 17beta-estradiol in cancer are mediated by estrogen receptor signaling at the plasma membrane. Front Physiol 2: 30
4. Adlanmerini M, Solinhac R, Abot A, Fabre A, Raymond-Letron I, Guihot AL, Boudou F, Sautier L, Vessieres E, Kim SH et al (2014) Mutation of the palmitoylation site of estrogen receptor alpha in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proc Natl Acad Sci U S A 111: E283-E290
5. Arnal JF, Lenfant F, Flouriot G, Tremollieres F, Laurell H, Fontaine C, Krust A, Chambon P, Gourdy P (2012) From in vivo gene targeting of estrogen receptors to optimisation of their modulation in menopause. Br J Pharmacol 165: 57-66
6. Ascenzi P, Bocedi A, Marino M (2006) Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med 27: 299-402
7. Billon-Gales A, Fontaine C, Douin-Echinard V, Delpy L, Berges H, Calippe B, Lenfant F, Laurell H, Guery JC, Gourdy P et al (2009) Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice. Circulation 120: 2567-2576
8. Billon-Gales A, Krust A, Fontaine C, Abot A, Flouriot G, Toutain C, Berges H, Gadeau AP, Lenfant F, Gourdy P et al (2011) Activation function 2 (AF2) of estrogen receptor-{alpha} is required for the atheroprotective action of estradiol but not to accelerate endothelial healing. Proc Natl Acad Sci U S A 108: 13311-13316
9. Bjornstrom L, Sjoberg M (2002) Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. Mol Endocrinol 16: 2202-2214
10. Boudot A, Kerdivel G, Habauzit D, Eeckhoute J, Le Dily F, Flouriot G, Samson M, Pakdel F (2011) Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells. PLoS ONE 6: e20898
11. Brouchet L, Krust A, Dupont S, Chambon P, Bayard F, Arnal JF (2001) Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation 103: 423-428
12. Chambliss KL, Wu Q, Oltmann S, Konaniah ES, Umetani M, Korach KS, Thomas GD, Mineo C, Yuhanna IS, Kim SH et al (2010) Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest 120: 2319-2330
13. Coelingh Bennink HJ, Simoncini T, Genazzani A, Kubista E (2008a) Estetrol, a pregnancy-specific human steroid, prevents and suppresses mammary tumor growth in a rat model. Climacteric 11(Suppl 1): 29
14. Coelingh Bennink HJ, Heegaard AM, Visser M, Holinka CF, Christiansen C (2008b) Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model. Climacteric 11(Suppl 1): 2-14
15. Coelingh Bennink HJ, Skouby S, Bouchard P, Holinka CF (2008c) Ovulation inhibition by estetrol in an in vivo model. Contraception 77: 186-190
16. Fontaine C, Abot A, Billon-Gales A, Flouriot G, Berges H, Grunenwald E, Vinel A, Valera MC, Gourdy P, Arnal JF (2013) Tamoxifen elicits atheroprotection through estrogen receptor alpha AF-1 but does not accelerate reendothelialization. Am J Pathol 183: 304-312
17. Gaben AM, Saucier C, Bedin M, Redeuilh G, Mester J (2004) Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase. Mol Endocrinol 18: 2700-2713
18. Giretti MS, Montt Guevara MM, Cecchi E, Mannella P, Palla G, Spina S, Bernacchi G, Di Bello S, Genazzani AR, Genazzani AD et al (2014) Effects of estetrol on migration and invasion in T47-D breast cancer cells through the actin cytoskeleton. Front Endocrinol 5: 80
19. Hagen AA, Barr M, Diczfalusy E (1965) Metabolism of 17-beta-oestradiol-4-14-C in early infancy. Acta Endocrinol 49: 207-220
20. Hammond GL, Hogeveen KN, Visser M, Coelingh Bennink HJ (2008) Estetrol does not bind sex hormone binding globulin or increase its production by human HepG2 cells. Climacteric 11(Suppl 1): 41-46
21. Hewitt SC, Deroo BJ, Hansen K, Collins J, Grissom S, Afshari CA, Korach KS (2003) Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen. Mol Endocrinol 17: 2070-2083
22. Holinka CF, Gurpide E (1979) In vivo effects of estetrol on the immature rat uterus. Biol Reprod 20: 242-246
23. Holinka CF, Brincat M, Coelingh Bennink HJ (2008) Preventive effect of oral estetrol in a menopausal hot flush model. Climacteric 11(Suppl 1): 15-21
24. Hsieh RW, Rajan SS, Sharma SK, Guo Y, DeSombre ER, Mrksich M, Greene GL (2006) Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity. J Biol Chem 281: 17909-17919
25. Huet G, Merot Y, Le Dily F, Kern L, Ferriere F, Saligaut C, Boujrad N, Pakdel F, Metivier R, Flouriot G (2008) Loss of E-cadherin-mediated cell contacts reduces estrogen receptor alpha (ER alpha) transcriptional efficiency by affecting the respective contribution exerted by AF1 and AF2 transactivation functions. Biochem Biophys Res Commun 365: 304-309
26. Jeyakumar M, Carlson KE, Gunther JR, Katzenellenbogen JA (2011) Exploration of dimensions of estrogen potency: parsing ligand binding and coactivator binding affinities. J Biol Chem 286: 12971-12982
27. Knauf C, Prevot V, Stefano GB, Mortreux G, Beauvillain JC, Croix D (2001) Evidence for a spontaneous nitric oxide release from the rat median eminence: influence on gonadotropin-releasing hormone release. Endocrinology 142: 2343-2350
28. Kraus WL, Montano MM, Katzenellenbogen BS (1993) Cloning of the rat progesterone receptor gene 5′-region and identification of two functionally distinct promoters. Mol Endocrinol 7: 1603-1616
29. La Rosa P, Pesiri V, Leclercq G, Marino M, Acconcia F (2012) Palmitoylation regulates 17beta-estradiol-induced estrogen receptor-alpha degradation and transcriptional activity. Mol Endocrinol 26: 762-774
30. Lannigan DA (2003) Estrogen receptor phosphorylation. Steroids 68: 1-9
31. Le Romancer M, Poulard C, Cohen P, Sentis S, Renoir JM, Corbo L (2011) Cracking the estrogen receptor's posttranslational code in breast tumors. Endocr Rev 32: 597-622
32. Mallat Z, Tedgui A (2007) Cytokines as regulators of atherosclerosis in murine models. Curr Drug Targets 8: 1264-1272
33. McKenna NJ, O'Malley BW (2001) Nuclear receptors, coregulators, ligands, and selective receptor modulators: making sense of the patchwork quilt. Ann N Y Acad Sci 949: 3-5
34. Melamed M, Castano E, Notides AC, Sasson S (1997) Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol. Mol Endocrinol 11: 1868-1878
35. Merot Y, Metivier R, Penot G, Manu D, Saligaut C, Gannon F, Pakdel F, Kah O, Flouriot G (2004) The relative contribution exerted by AF-1 and AF-2 transactivation functions in estrogen receptor alpha transcriptional activity depends upon the differentiation stage of the cell. J Biol Chem 279: 26184-26191
36. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F (2003) Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751-763
37. O'Malley BW, McGuire WL (1968) Studies on the mechanism of estrogen-mediated tissue differentiation: regulation of nuclear transcription and induction of new RNA species. Proc Natl Acad Sci U S A 60: 1527-1534
38. Penot G, Le Peron C, Merot Y, Grimaud-Fanouillere E, Ferriere F, Boujrad N, Kah O, Saligaut C, Ducouret B, Metivier R et al (2005) The human estrogen receptor-alpha isoform hERalpha46 antagonizes the proliferative influence of hERalpha66 in MCF7 breast cancer cells. Endocrinology 146: 5474-5484
39. Scheidt HA, Badeau RM, Huster D (2010) Investigating the membrane orientation and transversal distribution of 17beta-estradiol in lipid membranes by solid-state NMR. Chem Phys Lipids 163: 356-361
40. Schnoes KK, Jaffe IZ, Iyer L, Dabreo A, Aronovitz M, Newfell B, Hansen U, Rosano G, Mendelsohn ME (2008) Rapid recruitment of temporally distinct vascular gene sets by estrogen. Mol Endocrinol 22: 2544-2556
41. Smith CL, O'Malley BW (2004) Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25: 45-71
42. Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius KJ, Jarvius J, Wester K, Hydbring P, Bahram F, Larsson LG et al (2006) Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 3: 995-1000
43. Sun J, Nawaz Z, Slingerland JM (2007) Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen-responsive elements in breast cancer cells. Mol Endocrinol 21: 2651-2662
44. Toutain CE, Filipe C, Billon A, Fontaine C, Brouchet L, Guery JC, Gourdy P, Arnal JF, Lenfant F (2009) Estrogen receptor alpha expression in both endothelium and hematopoietic cells is required for the accelerative effect of estradiol on reendothelialization. Arterioscler Thromb Vasc Biol 29: 1543-1550
45. Ueda K, Karas RH (2013) Emerging evidence of the importance of rapid, non-nuclear estrogen receptor signaling in the cardiovascular system. Steroids 78: 589-596
46. Valera MC, Gratacap MP, Gourdy P, Lenfant F, Cabou C, Toutain CE, Marcellin M, Saint Laurent N, Sie P, Sixou M et al (2012) Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor alpha. Blood 120: 1703-1712
47. Vasudevan N, Pfaff DW (2007) Membrane-initiated actions of estrogens in neuroendocrinology: emerging principles. Endocr Rev 28: 1-19
48. Visser M, Foidart JM, Coelingh Bennink HJ (2008) In vitro effects of estetrol on receptor binding, drug targets and human liver cell metabolism. Climacteric 11(Suppl 1): 64-68
49. Visser M, Coelingh Bennink HJ (2009) Clinical applications for estetrol. J Steroid Biochem Mol Biol 114: 85-89
50. Watanabe H, Suzuki A, Kobayashi M, Takahashi E, Itamoto M, Lubahn DB, Handa H, Iguchi T (2003) Analysis of temporal changes in the expression of estrogen-regulated genes in the uterus. J Mol Endocrinol 30: 347-358
51. Weber C, Zernecke A, Libby P (2008) The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 8: 802-815
52. Wu Q, Chambliss K, Umetani M, Mineo C, Shaul PW (2011) Non-nuclear estrogen receptor signaling in the endothelium. J Biol Chem 286: 14737-14743
53. Yamamoto H, Liljestrand HM (2004) Partitioning of selected estrogenic compounds between synthetic membrane vesicles and water: effects of lipid components. Environ Sci Technol 38: 1139-1147